European Archives - Page 14 of 1122 - European Medical Journal

Obesity Worsens Pain and Function in Older Adults with Osteoarthritis: WCO 2025

A study from the Hertfordshire Cohort has found that older adults with obesity and radiographic knee osteoarthritis experience greater pain and impaired function compared to their non-obese peers.

Family History of Diabetes Linked to Faster CKD Progression

A large study of over 6,500 CKD patients has found that having a first-degree relative with diabetes significantly increases the risk of kidney disease progression, regardless of whether the patient has diabetes or a genetic predisposition.

Hyaluronic Acid and Laser Therapy for Rosacea

An increasingly studied adjunctive therapy is Hyaluronic Acid, known for its hydrating, regenerative, and anti-inflammatory properties.

Simultaneous Acne and Scar Treatment Proves More Effective

Beyond clinical outcomes, the simultaneous approach offered additional benefits: reduced overall treatment time and higher patient satisfaction.

New Castleman Disease Subtype Identified

A newly recognised subtype of Castleman disease (CD), termed oligocentric CD (OligoCD), has been identified and characterised through the ACCELERATE natural history registry….

Survival and Recurrence in Upper Tract Urothelial Cancer

Discover a recent study that has provided crucial new insights into the treatment of upper tract urothelial carcinoma.

Pulmonary Embolism in Youth Carries Notable Mortality Risk

New data reveal that acute pulmonary embolism, though rare in children and adolescents, carries a significant risk of death.

Preoperative MRI May Not Improve Outcomes in HER2-Positive Breast Cancer

Understand how preoperative MRI does not boost survival in HER2-positive, HR-negative breast cancer

First Trial Shows Psilocybin is Safe and Effective in Parkinson’s Disease

Discover how psilocybin therapy could transform Parkinson’s care – read more about this promising pilot trial and future directions.

New Blood Test Shows Promise in Predicting Melanoma Recurrence Risk

A new study from the COMBI-AD trial shows that circulating tumour DNA (ctDNA) testing can accurately predict recurrence and survival in stage III melanoma, offering a potential tool for personalising treatment.